Mycenax Biotech (4726.TWO) Earnings Analysis
Mycenax Biotech (4726.TWO) next reports earnings on 2026-08-06, consensus EPS -0.32 TWD. Last quarter (2026-03-10) it beat with EPS -0.26 TWD vs -0.33 TWD est (+21.2%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -11.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4726.TWO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.32 TWD |
| Revenue estimate | 0.21B |
4726.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-10 | -0.26 TWD | -0.33 TWD | +21.2% | Beat |
| 2025-11-10 | -0.63 TWD | 0.12 TWD | -625% | Miss |
| 2025-03-12 | -0.40333 TWD | -0.28 TWD | -44% | Miss |
| 2024-08-09 | -0.49 TWD | -0.63 TWD | +22.2% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
4726.TWO valuation and analyst view
| Trailing P/E | -11.71 |
|---|---|
| Trailing EPS | -2.08936 TWD |
| Price / book | 3.47 |
| Dividend yield | 0.00% |
| Market cap | 5.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Mycenax Biotech (4726.TWO)'s next earnings date?
Mycenax Biotech is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.32 TWD and revenue estimate of 0.21B.
Did 4726.TWO beat earnings last quarter?
In its 2026-03-10 report, 4726.TWO posted EPS of -0.26 TWD versus a -0.33 TWD estimate — a beat of 21.2%.
What is 4726.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 4726.TWO beat estimates 2 times (50%).
What is 4726.TWO's current P/E ratio and EPS?
4726.TWO trades at a trailing P/E of -11.71 on trailing EPS of -2.089361620648719 TWD.
What do analysts rate 4726.TWO?
4726.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.